Cadence Registry_(Protocol #:GBL-CAD-19-11164)_(Study #:0085/0470).
Research type
Research Study
Full title
CADENCE Registry - Cold Agglutinin Disease Real World Evidence Registry
IRAS ID
277297
Contact name
Jun Su
Contact email
Sponsor organisation
Sanofi US Services Inc
Duration of Study in the UK
5 years, 0 months, 1 days
Research summary
Cold agglutinin disease (CAD) is a rare type of disease, and information on this medical condition is currently very limited. The purpose of this survey-type study is to collect data so that the following can be better understood: how the disease progresses, complications, treatment impact, and patient experiences. The study also aims to gain an understanding of how CAD initially develops, and also help to raise awareness of this disease and its treatment.
REC name
North East - Tyne & Wear South Research Ethics Committee
REC reference
20/NE/0122
Date of REC Opinion
18 Jun 2020
REC opinion
Further Information Favourable Opinion